Giovanni Battista Migliori

18 ta ish

Istituti Clinici Scientifici Maugeri

AkademScholarda batafsil koʻrsatkichlar

Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Shama D. Ahuja, David Ashkin, Monika Avendano +70
Sharh maqolaOchiq kirish20129 iqtibos
ABI
Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
Emanuele Pontali, Mario Raviǵlione, Giovanni Battista Migliori
Sharh maqolaOchiq kirish20195 iqtibos
ABI
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
Dennis Falzon, Neel R. Gandhi, Giovanni Battista Migliori +11
Sharh maqolaOchiq kirish20124 iqtibos
ABI
Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis
Mayara Lisboa Bastos, Hamidah Hussain, Karin Weyer +82
Sharh maqolaOchiq kirish20144 iqtibos
ABI
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97
Sharh maqolaOchiq kirish20184 iqtibos
ABI
Standard Short-Course Chemotherapy for Drug-Resistant Tuberculosis
Marcos Espinal, Sang‐Jae Kim, Pedro Suarez +7
Maqola20003 iqtibos
ABI
Faster for less: the new “shorter” regimen for multidrug-resistant tuberculosis
Giovanni Sotgiu, Simon Tiberi, Lia D’Ambrosio +18
BoshqaOchiq kirish20163 iqtibos
ABI
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Dennis Falzon, E. Jaramillo, Holger J. Schünemann +43
MaqolaOchiq kirish20113 iqtibos
ABI
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis
Giovanni Battista Migliori, Giovanni Sotgiu, Neel R. Gandhi +16
Sharh maqolaOchiq kirish20122 iqtibos
ABI
WHO recommendations on shorter treatment of multidrug-resistant tuberculosis
Giovanni Sotgiu, Simon Tiberi, Lia D’Ambrosio +3
MaqolaOchiq kirish20162 iqtibos
ABI
Tuberculosis control in prisons: current situation and research gaps
Masoud Dara, Colleen Acosta, Natalie V. S. Vinkeles Melchers +8
Sharh maqolaOchiq kirish20152 iqtibos
ABI
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
Simon Tiberi, Nelita du Plessis, Gerhard Walzl +11
Sharh maqola20182 iqtibos
ABI
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
Denise Rossato Silva, Margareth Pretti Dalcolmo, Simon Tiberi +9
Sharh maqola20182 iqtibos
ABI
Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings
Giovanni Sotgiu, Simon Tiberi, Rosella Centis +4
Maqola20162 iqtibos
ABI
Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis
S.K. Abidi, Jay Achar, M.M. Assao Neino +34
MaqolaOchiq kirishTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos
ABI
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study
Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23
MaqolaOchiq kirish20240 iqtibos
ABI
Effectiveness and Safety of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis: Prospective Cohort Study
Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23
PreprintOchiq kirishTuberculosis Research and EpidemiologySSRN Electronic Journal20240 iqtibos
ABI
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis
Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97
Sharh maqolaOchiq kirishTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 iqtibos
ABI